Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markers.
Bäckman C, Zhang Y, Hoffer BJ, Tomac AC
This study demonstrates that short interfering RNAs effectively suppress genes involved in the dopaminergic system, including NR4A2, in mammalian cells. The authors suggest this technique could serve as a tool for analyzing gene function or potentially inform future gene therapy strategies.
- siRNAs successfully knock down NR4A2 and other dopaminergic markers in cell cultures.
- The method uses a U6 promoter to drive siRNA expression alongside reporter genes.
- Results indicate potential for in vivo delivery of siRNAs to suppress dopamine-related genes.
- This is preclinical molecular biology with no human data or clinical application.
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.
Wallen-Mackenzie A, Mata de Urquiza A, Petersson S, Rodriguez FJ, Friling S, Wagner J, Ordentlich P, Lengqvist J, Heyman RA, Arenas E, Perlmann T
RXR ligands activate Nurr1-RXR heterodimers to increase the survival of dopaminergic neurons in embryonic tissue. This mechanism identifies RXR-Nurr1 interactions as a potential therapeutic target for neurodegenerative diseases.
- Endogenous RXR ligands exist in the developing central nervous system.
- These ligands activate Nurr1-RXR heterodimers to promote neuronal survival.
- The study focuses on embryonic tissue, not adult or clinical settings.
- No human trials or NR4A2 variant data are included.
The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production.
Bassett MH, Suzuki T, Sasano H, White PC, Rainey WE
NURR1 and another related protein, NGFIB, play a key role in controlling the production of aldosterone, a hormone critical for blood pressure regulation, by turning on the gene that makes aldosterone synthase. These proteins are activated by angiotensin II, the main signal that boosts aldosterone in the body, and they bind directly to the gene to increase its activity.
- NURR1 and NGFIB boost aldosterone production by activating the CYP11B2 gene
- Angiotensin II turns on NURR1 and NGFIB, linking them to hormone regulation
- NURR1 is mainly found in the adrenal zone that makes aldosterone
- Blocking a specific enzyme reduces NURR1 activity and aldosterone gene expression
- Three DNA sites, including one for NURR1, are needed for full gene activation
Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice.
Erdö F, Trapp T, Mies G, Hossmann KA
This study maps changes in various proteins, including Nurr1, within mouse brains following a stroke-like injury. It identifies that Nurr1 moves from the nucleus to the cytoplasm after ischemic damage, highlighting regional protein regulation during brain injury.
- Researchers analyzed protein expression in mouse brains after inducing focal cerebral ischemia.
- Nurr1 translocates from the nucleus to the cytosol following ischemic injury in mice.
- The study highlights diverse up- and down-regulation patterns of various proteins post-injury.
- Findings emphasize the importance of regional analysis for interpreting proteomic data in brain injury.
Organization and development of corticocortical associative neurons expressing the orphan nuclear receptor Nurr1.
Arimatsu Y, Ishida M, Kaneko T, Ichinose S, Omori A
This study identifies Nurr1 as a marker for specific excitatory neurons in the rat cerebral cortex that form long-range connections within the same brain hemisphere. It demonstrates that these neurons develop from embryonic day 18 and likely play a role in establishing normal cortical circuitry.
- Nurr1 marks excitatory glutamatergic neurons in specific layers of the rat neocortex.
- These Nurr1-positive neurons project to other areas within the same cerebral hemisphere.
- The study uses adult rats and does not involve human subjects or clinical data.
- Findings suggest a role for Nurr1 in cortical circuit formation, but this is preclinical.
Molecular mechanisms underlying midbrain dopamine neuron development and function.
Smidt MP, Smits SM, Burbach JP
This review outlines how transcription factors including Nurr1 (NR4A2) drive the development of dopamine neurons and explains how genetic disruptions in these pathways lead to functional deficits. It discusses the consequences of losing essential developmental genes and analyzes the system's potential to adapt to such dysfunction.
- Nurr1 is a key transcription factor for midbrain dopamine neuron development.
- Genetic ablation of Nurr1 disrupts the mesencephalic dopaminergic system.
- The paper reviews how dopamine homeostasis changes affect neuronal function.
- It analyzes the capacity of dopamine systems to adapt to gene dysfunction.
- This is a general review, not specific to NR4A2 syndrome variants.
PIASgamma represses the transcriptional activation induced by the nuclear receptor Nurr1.
Galleguillos D, Vecchiola A, Fuentealba JA, Ojeda V, Alvarez K, Gómez A, Andrés ME
This study identifies PIASgamma as a protein that suppresses the activity of Nurr1, the transcription factor affected in NR4A2-related syndromes. It demonstrates this interaction occurs in cell nuclei and involves specific molecular mechanisms within rodent brain tissue.
- PIASgamma binds to Nurr1 and represses its ability to activate target genes.
- The repression mechanism does not depend on known SUMOylation sites on Nurr1.
- Both proteins co-exist in the nuclei of rodent central nervous system cells.
Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.
Castelo-Branco G, Wagner J, Rodriguez FJ, Kele J, Sousa K, Rawal N, Pasolli HA, Fuchs E, Kitajewski J, Arenas E
This study identifies specific Wnt proteins that control the growth and maturation of dopamine-producing neurons in developing brains. It demonstrates that different Wnt signals drive precursor cells to either multiply or transform into functional neurons through distinct molecular pathways.
- Wnt-3a increases the number of Nurr1-positive precursor cells without creating mature neurons.
- Wnt-1 promotes the proliferation of these precursors by regulating cell cycle proteins.
- Wnt-5a helps precursors mature into dopamine neurons by activating specific gene markers.
- Blocking Wnt signals stops both the growth and maturation of these brain cells.
The transcription factor Nurr1 in human NT2 cells and hNT neurons.
Misiuta IE, Anderson L, McGrogan MP, Sanberg PR, Willing AE, Zigova T
This study confirms that human NT2 cells and their derived hNT neurons naturally express the Nurr1 protein and mRNA. The findings show that Nurr1 is present alongside dopaminergic markers, suggesting it plays a role in the development of these specific neuron types.
- Human NT2 precursor cells express Nurr1 protein and mRNA.
- Differentiated hNT neurons also express Nurr1 independently of differentiation time.
- Nurr1 co-expresses with tyrosine hydroxylase in hNT neurons.
- The study uses human cell lines, not animal models or patients.
- Results describe basic biology without testing any treatments.
Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1.
Liu D, Jia H, Holmes DI, Stannard A, Zachary I
This study shows that vascular endothelial growth factor triggers the expression of NR4A2 (Nurr1) and related genes in blood vessel cells through specific signaling pathways. It identifies these receptors as early mediators of endothelial function but does not investigate their role in brain development or neurodegenerative disease.
- VEGF induces NR4A2, Nur77, and Nor1 expression in human endothelial cells.
- This induction occurs via KDR receptor signaling involving calcium and protein kinase C.
- The research focuses on blood vessel biology, not neurological function or disease.
- No clinical data or patient outcomes are presented.
Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons.
Smits SM, Ponnio T, Conneely OM, Burbach JP, Smidt MP
This study confirms that the NR4A2 protein is required to turn on specific genes for dopamine transport and storage in developing brain cells, but it does not control the gene for the initial dopamine-making enzyme. The findings are based entirely on mouse models and do not provide direct evidence for human treatment strategies or clinical outcomes.
- NR4A2 is essential for activating dopamine transporter genes in developing midbrain neurons.
- The protein does not control the gene for the initial dopamine synthesis enzyme.
- Research relies on mouse models, limiting direct applicability to human patients.
- Findings describe basic molecular mechanisms rather than clinical interventions or therapies.
The orphan steroid receptor Nur77 family member Nor-1 is essential for early mouse embryogenesis.
DeYoung RA, Baker JC, Cado D, Winoto A
Nor-1 is essential for early mouse embryogenesis, as its absence causes embryonic lethality around day 8.5 due to failed gastrulation and mesoderm defects. This study highlights a critical developmental role for Nor-1 that is distinct from the dopaminergic functions associated with Nurr1.
- Nor-1 loss causes embryonic death in mice at day 8.5 of gestation.
- Mutant embryos fail to complete gastrulation and show mesoderm accumulation.
- This contrasts with Nur77 deficiency, which shows no gross phenotype in mice.
- The findings focus on early development rather than dopamine neuron function.
NR4A2 mutations are rare among European patients with familial Parkinson's disease.
Wellenbrock C, Hedrich K, Schäfer N, Kasten M, Jacobs H, Schwinger E, Hagenah J, Pramstaller PP, Vieregge P, Klein C
NR4A2 mutations are very uncommon in European families with Parkinson's disease, suggesting they are not a common cause of inherited Parkinson's in this population.
- NR4A2 mutations are rare in European familial Parkinson's cases
- Not a major genetic cause of inherited Parkinson's in this group
- Other genes likely play bigger roles in familial Parkinson's
- NR4A2 is not a primary target for genetic testing in this context
Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
Ojeda V, Fuentealba JA, Galleguillos D, Andrés ME
This rat study shows that damaging dopamine neurons triggers a rapid increase in Nurr1 protein and mRNA in the substantia nigra. The findings suggest Nurr1 helps compensate for dopamine loss, but the results come from an animal model of neurotoxicity rather than human genetics or clinical trials.
- Rats injected with a dopamine-toxin showed increased Nurr1 levels in key brain regions within 24 hours.
- Nurr1 appears to help compensate for dopamine depletion in adult rat brains.
- The study uses a toxic lesion model, not genetic NR4A2 variants or human patients.
- Results describe molecular responses in rats and do not translate directly to human therapy.
Genetic analysis of Nurr1 haplotypes in Parkinson's disease.
Tan EK, Chung H, Zhao Y, Shen H, Chandran VR, Tan C, Teoh ML, Yih Y, Pavanni R, Wong MC
This study found no strong link between variations in the Nurr1 gene and Parkinson's disease in the people studied, including a rare variant that appeared only in one patient. Nurr1 gene activity levels were similar in patients and healthy individuals, and common genetic patterns in the gene did not differ between groups.
- No major role for Nurr1 gene variants in most Parkinson's cases
- A rare variant found in only one patient was not linked to disease
- Nurr1 gene activity levels were unchanged in patients
- Common genetic patterns in Nurr1 did not differ between patients and controls
Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells.
Hermanson E, Joseph B, Castro D, Lindqvist E, Aarnisalo P, Wallén A, Benoit G, Hengerer B, Olson L, Perlmann T
The transcription factor Nurr1 directly controls the production and storage of dopamine in developing nerve cells. Without sufficient Nurr1, key enzymes and transporters required for dopamine function are deregulated.
- Nurr1 increases dopamine content in dopaminergic cells.
- Nurr1 upregulates AADC, an enzyme needed for dopamine synthesis.
- Nurr1 upregulates VMAT2, a transporter that stores dopamine.
- VMAT2 levels drop when Nurr1 expression is removed.
- Retinoids do not replicate these specific effects on dopamine machinery.
A linkage study of candidate loci in familial Parkinson's Disease.
Wirdefeldt K, Burgess CE, Westerberg L, Payami H, Schalling M
This study found no strong evidence linking known Parkinson's disease genes to 12 families with inherited Parkinson's, though some weak signals suggest possible genetic differences between families. The results do not point to any specific gene as responsible for these cases.
- No clear genetic link found to known Parkinson's genes
- Some weak signals suggest possible genetic differences between families
- Results do not rule out all genetic causes
- Study focused on familial Parkinson's, not NR4A2-related syndromes
Elevated locomotor activity without altered striatal dopamine contents in Nurr1 heterozygous mice after acute exposure to methamphetamine.
Bäckman C, You ZB, Perlmann T, Hoffer BJ
Mice with one copy of the Nurr1 gene show increased movement after methamphetamine exposure, even though their total brain dopamine levels remain normal. This suggests that having only one functional NR4A2 gene may affect how dopamine is released or cleared in the brain rather than reducing its overall amount.
- Mice with one Nurr1 copy move more after methamphetamine exposure.
- Total striatal dopamine levels stay normal in these mice.
- The mutation alters locomotor activity without changing dopamine content.
- Results hint at altered dopamine release or clearance dynamics.
NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits.
Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L
This study found no strong link between specific changes in the NURR1 gene's promoter region and schizophrenia or Parkinson's disease in the groups studied. While some weak associations with personality traits or related features were seen, they did not hold up after accounting for multiple comparisons.
- No clear link found between NURR1 promoter variants and schizophrenia or Parkinson’s
- Previous NURR1 mutations were seen in psychiatric patients, but not in this study’s promoter analysis
- Some weak hints at personality links, but not statistically significant after correction
- No changes were found in exon 1 of NURR1 in Parkinson’s patients
- Findings suggest these promoter variants are unlikely to increase disease risk
Activation incarnate.
Privalsky ML
This paper reports that the Nurr1 protein can function without binding to a chemical ligand, revealing a new mechanism for how this transcription factor is regulated. It provides fundamental molecular insight into Nurr1 biology but does not involve human patients or direct therapeutic applications.
- Nurr1 assumes active shapes without needing a ligand agonist.
- The study clarifies how nuclear receptors regulate themselves.
- Three new publications demonstrate this ligand-independent activation.
- Findings focus on basic transcriptional regulation mechanisms.
Point mutations in exon 1 of the NR4A2 gene are not a major cause of familial Parkinson's disease.
Zimprich A, Asmus F, Leitner P, Castro M, Bereznai B, Homann N, Ott E, Rutgers AW, Wieditz G, Trenkwalder C, Gasser T
Point mutations in exon 1 of the NR4A2 gene are not a common cause of familial Parkinson's disease, suggesting that this specific genetic change is unlikely to be responsible for inherited cases of the condition.
- NR4A2 exon 1 mutations are not a major cause of familial Parkinson's
- These mutations are rare in inherited Parkinson's cases
- Other genetic factors likely play bigger roles in familial Parkinson's
Parathyroid hormone induces the nuclear orphan receptor NOR-1 in osteoblasts.
Pirih FQ, Nervina JM, Pham L, Aghaloo T, Tetradis S
Parathyroid hormone triggers the production of a protein called NOR-1 in bone-forming cells, primarily through a specific signaling pathway involving cAMP and PKA. This finding shows how PTH influences bone cell activity at the genetic level.
- PTH turns on the NOR-1 gene in bone cells
- NOR-1 is part of a family of genes linked to brain and development
- The effect is driven by cAMP-PKA signaling, not calcium or PKC
- NOR-1 is a direct target of PTH, not dependent on new protein synthesis
- This pathway may influence bone growth and remodeling
Expression of depolarization-induced immediate early gene proteins in PC12 cells.
Liu W, Feldman JD, Machado HB, Vician LJ, Herschman HR
This study measures how quickly specific proteins, including Nurr-1, appear in rat pheochromocytoma cells after chemical stimulation. It provides basic timing data on protein synthesis but offers no insight into human disease mechanisms or treatment options.
- Researchers tracked four immediate early gene proteins in PC12 rat cells.
- Nurr-1 protein levels peaked between two and four hours post-stimulation.
- Other proteins like PIM-1, KID-1, and SIK showed distinct timing patterns.
- The study uses only cell lines with no human or animal disease models.
Sonic hedgehog and FGF8 collaborate to induce dopaminergic phenotypes in the Nurr1-overexpressing neural stem cell.
Kim TE, Lee HS, Lee YB, Hong SH, Lee YS, Ichinose H, Kim SU, Lee MA
This study demonstrates that combining Nurr1 overexpression with specific growth factors (Shh and FGF8) directs mouse neural stem cells to become dopaminergic neurons in a laboratory setting. The authors propose this method could generate unlimited dopamine-producing cells for potential future cell replacement therapies in Parkinson's disease.
- Nurr1 overexpression primes mouse stem cells to respond to Shh and FGF8 signals.
- The combination induces midbrain dopaminergic phenotypes in immortalized neural stem cells.
- Findings rely entirely on mouse cell lines, not human patients or clinical data.
- The work focuses on basic mechanisms of neuron specification rather than treatment outcomes.
Decreased ethanol preference and wheel running in Nurr1-deficient mice.
Werme M, Hermanson E, Carmine A, Buervenich S, Zetterström RH, Thorén P, Ogren SO, Olson L, Perlmann T, Brené S
Mice with one copy of the Nurr1 gene show reduced interest in ethanol and less compulsive wheel running compared to normal mice. This suggests that lower levels of this protein may decrease reward-seeking behaviors, but these findings are based solely on animal models.
- Heterozygous Nurr1 deficiency reduces ethanol consumption in adult mice.
- Reduced Nurr1 levels also decrease compulsive wheel running behavior.
- The study links Nurr1 to the reinforcing properties of rewards.
- Genetic mapping identifies Nurr1 as a candidate for ethanol preference traits.
- All evidence comes from mouse models, not human patients.
Transcription factors in the development of midbrain dopamine neurons.
Burbach JP, Smits S, Smidt MP
This review explains that midbrain dopamine neurons require two distinct transcription factor cascades to develop and survive. It highlights Nurr1 (NR4A2) as essential for producing dopamine and other genes like Lmx1b and Ptx3 for structural formation.
- Nurr1 is required for synthesizing the neurotransmitter dopamine in midbrain neurons.
- Homeobox genes like Lmx1b and Engrailed drive early development and survival.
- Ptx3 induction coincides with dopamine enzyme production and substantia nigra formation.
- Both transcription factor cascades are necessary for neuron survival during development.
Transcriptional control of dopamine neuron development.
Wallén A, Perlmann T
This review outlines the genetic roadmap for developing dopamine neurons, highlighting Nurr1 (NR4A2) as a key factor alongside others like Lmx1b and Pitx3. It explains how understanding these factors helps scientists engineer dopamine cells from stem cells in the lab.
- Nurr1 is one of several transcription factors essential for postmitotic dopamine neuron development.
- Early dopamine progenitor identity relies on sonic hedgehog and FGF8 signals.
- Lab-engineered dopamine neurons use this genetic knowledge for potential Parkinson's therapies.
Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.
Simon HH, Bhatt L, Gherbassi D, Sgadó P, Alberí L
This review outlines the specific sequence of transcription factors, including Nurr1 (NR4A2), that guide midbrain dopaminergic neurons to develop and survive. It establishes that Nurr1 is essential for expressing the dopamine-producing phenotype and regulating related genes, while other factors like Engrailed-1/2 are required for long-term survival.
- Nurr1 drives the expression of genes needed for dopamine synthesis and transport.
- Engrailed-1 and -2 are critical for the survival of these neurons after they form.
- The paper reviews general developmental biology without testing treatments or human outcomes.
- It does not address NR4A2 mutations, specific patient phenotypes, or clinical interventions.
Dopaminergic neuronal differentiation from rat embryonic neural precursors by Nurr1 overexpression.
Kim JY, Koh HC, Lee JY, Chang MY, Kim YC, Chung HY, Son H, Lee YS, Studer L, McKay R, Lee SH
Overexpressing Nurr1 in rat brain precursor cells induces some dopaminergic features in a dish, but the resulting cells are immature and fail to function or improve behavior when transplanted into living animals. This study confirms that Nurr1 alone is insufficient to create fully functional dopamine neurons for therapy, highlighting the need for additional factors. These findings do not provide direct evidence for treating NR4A2-related syndromes in humans.
- Nurr1 induces immature dopaminergic markers in rat precursor cells in vitro.
- Transplanted cells show limited survival and no functional improvement in animal models.
- The study uses rat embryonic precursors, not human tissue or patients.
- Results indicate Nurr1 alone cannot generate fully functional dopamine neurons for therapy.
Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
Wang Z, Benoit G, Liu J, Prasad S, Aarnisalo P, Liu X, Xu H, Walker NP, Perlmann T
This study reveals that the Nurr1 protein lacks a binding pocket for small molecules, meaning it functions without traditional chemical triggers. The research focuses on the physical structure of the protein rather than its role in disease or potential treatments.
- Nurr1 is a ligand-independent nuclear receptor with no cavity for small molecule binding.
- The protein structure differs from typical receptors that rely on ligand activation.
- Transcriptional activity correlates with the stability of the Nurr1 protein structure.
- This work defines a new structural class of nuclear receptors without clinical implications.
Parkinson's disease: piecing together a genetic jigsaw.
Dekker MC, Bonifati V, van Duijn CM
This review discusses the genetic causes of Parkinson's disease, noting that mutations in NR4A2 disrupt a specific signaling pathway. It highlights that while these genetic insights help explain familial cases, the mechanisms for common late-onset Parkinson's remain unclear due to gene-environment interactions.
- NR4A2 mutations affect a distinct signaling pathway in Parkinson's disease.
- Parkinson's genetics involve complex networks beyond simple protein aggregation.
- Common Parkinson's likely results from gene and environment interactions.
- The paper reviews monogenic forms and their population consequences.
Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner.
Kim KS, Kim CH, Hwang DY, Seo H, Chung S, Hong SJ, Lim JK, Anderson T, Isacson O
This study identifies the specific DNA binding sites on the tyrosine hydroxylase gene that Nurr1 uses to activate dopamine production in neurons. It confirms that Nurr1 directly controls this key enzyme but does not regulate the related noradrenergic pathway.
- Nurr1 directly activates the tyrosine hydroxylase gene promoter in dopaminergic cells.
- Three specific binding motifs (NL1, NL2, NL3) mediate this activation.
- NL3 shows the highest binding affinity to Nurr1 despite NL1 being critical for function.
- Nurr1 does not regulate the dopamine beta-hydroxylase promoter.
- This mechanism specifies dopamine neurotransmitter identity in developing neurons.
Regulation of NGFI-B expression during the ovulatory process.
Park JI, Park HJ, Lee YI, Seo YM, Chun SY
This study examines how the hormone LH regulates NGFI-B (NR4A2) and related genes in rat and human ovarian cells during ovulation. It identifies specific signaling pathways involved in this reproductive process but provides no information on neurodevelopment, brain function, or potential treatments for NR4A2-related syndromes.
- LH triggers rapid NGFI-B expression in rat and human ovarian granulosa cells.
- This induction requires protein kinase Czeta signaling pathways.
- Related genes Nurr1 and Nor1 also respond to LH stimulation.
- The research focuses solely on reproductive biology, not neurological function.
- No clinical data or therapeutic implications for NR4A2 disorders are presented.
Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1.
Ordentlich P, Yan Y, Zhou S, Heyman RA
The leukemia drug 6-mercaptopurine activates the NR4A2 protein in laboratory settings. This finding suggests a new biological mechanism for how the drug works but does not indicate it is a treatment for NR4A2-related syndromes.
- 6-mercaptopurine activates NR4A2 via its amino terminus in cell studies.
- The drug is currently used for leukemia and Crohn's disease, not NR4A2 syndrome.
- This mechanism explains antiproliferative effects, not therapeutic benefit for neurodevelopment.
- No clinical trials target NR4A2 activation using this drug.
The AF-1 domain of the orphan nuclear receptor NOR-1 mediates trans-activation, coactivator recruitment, and activation by the purine anti-metabolite 6-mercaptopurine.
Wansa KD, Harris JM, Yan G, Ordentlich P, Muscat GE
This study details the molecular mechanics of how the NOR-1 protein activates genes and responds to specific drugs in cell cultures. It identifies that a specific protein domain drives this activation and demonstrates that the chemotherapy drug 6-mercaptopurine can trigger this pathway. The findings suggest these proteins act as sensors for cellular stress caused by DNA damage.
- NOR-1 activates genes through its N-terminal AF-1 domain, not its ligand-binding domain.
- The drug 6-mercaptopurine directly activates NOR-1 in cell culture experiments.
- Other similar anti-metabolite drugs also activate this specific protein pathway.
- Researchers hypothesize NR4A proteins sense genotoxic stress from DNA damage.
- The study uses molecular biology techniques on cells, not human patients or animals.
The human tyrosine hydroxylase gene promoter.
Kessler MA, Yang M, Gollomp KL, Jin H, Iacovitti L
This study maps the regulatory DNA region controlling tyrosine hydroxylase, the enzyme that makes dopamine, and identifies binding sites for NR4A2 (Nurr1) within it. It confirms that NR4A2 directly interacts with the tyrosine hydroxylase promoter in a conserved manner across humans and rodents. This provides molecular evidence for how NR4A2 regulates dopamine production but offers no direct clinical guidance or treatment options.
- NR4A2 binding sites exist within the human tyrosine hydroxylase gene promoter.
- These regulatory regions are highly conserved between humans, mice, and rats.
- The study uses transgenic mice to validate promoter activity in dopamine-producing cells.
- No human clinical data or patient outcomes are reported.
Distribution of haplotypes derived from three common variants of the NR4A2 gene in Japanese patients with schizophrenia.
Iwayama-Shigeno Y, Yamada K, Toyota T, Shimizu H, Hattori E, Yoshitsugu K, Fujisawa T, Yoshida Y, Kobayashi T, Toru M, Kurumaji A, Detera-Wadleigh S, Yoshikawa T
This study found no strong link between common variations in the NR4A2 gene and schizophrenia in Japanese patients, suggesting NR4A2 is unlikely to be a major genetic risk factor for schizophrenia in this population.
- No significant genetic link found between NR4A2 variants and schizophrenia
- Three common NR4A2 gene variants were studied together
- Haplotypes from these variants showed no association with the disease
- Results suggest NR4A2 is not a major risk factor for schizophrenia in Japanese people
Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment.
Maira M, Martens C, Batsché E, Gauthier Y, Drouin J
This study details the molecular mechanism by which stress hormones activate NR4A2 family proteins in cells, showing that they must form pairs to function and that specific chemical signals enhance this pairing. It does not involve human patients or clinical outcomes for NR4A2-related syndromes.
- NR4A2 proteins require dimerization to bind DNA and activate gene transcription.
- Stress hormone signaling enhances the activity of these protein pairs via PKA.
- Coactivators recruit to dimers but not monomers to boost transcriptional output.
- The AF-1 domain mediates this potentiation mechanism in cell models.
Hzf-3 expression in the amygdala after establishment of conditioned taste aversion.
Ge H, Chiesa R, Peña de Ortiz S
This study shows that the NR4A2 protein increases in a specific part of the rat brain when they learn to avoid a bad taste. It suggests this protein helps process negative experiences but does not provide information on human development or treatment.
- NR4A2 levels rise in the rat amygdala during associative learning.
- The protein responds only when stimuli are paired together.
- Findings relate to basic brain function, not NR4A2 syndrome.
- No human data or clinical implications are presented.
The constitutive and inducible expression of Nurr1, a key regulator of dopaminergic neuronal differentiation, in human neural and non-neural cell lines.
Satoh J, Kuroda Y
This study confirms that Nurr1 mRNA is present in various human cell lines and increases when neurons are stimulated, but it fails to show that Nurr1 directly activates key genes involved in dopamine production or survival in the tested cells. The findings suggest that additional factors are required for Nurr1 to function effectively in regulating these genetic pathways. This work provides basic molecular context but offers no direct clinical insights or treatment options for NR4A2-related syndrome.
- Nurr1 mRNA is found in many human neural and non-neural cell lines.
- Stimulation of differentiated neurons increases Nurr1, NGFI-B, and NOR-1 levels.
- Overexpressing Nurr1 does not significantly change expression of 27 tested target genes.
- Effective transcriptional activation likely requires additional coactivators in precursor cells.